Full Press Release Details
AMERISOURCEBERGEN CORPORATION
SUMMARY SEGMENT INFORMATION
The following illustrates revised reportable segment revenue for the periods indicated
| Fiscal Year Ended September 30, 2021 | ||||||||||||||||||||
| Revenue | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Fiscal Year | |||||||||||||||
| (As Revised) | (As Revised) | (As Revised) | (As Revised) | (As Revised) | ||||||||||||||||
| U.S. Healthcare Solutions | $ | 51,572,581 | $ | 48,165,587 | $ | 50,375,842 | $ | 52,347,535 | $ | 202,461,545 | ||||||||||
| International Healthcare Solutions | 944,311 | 989,032 | 3,030,769 | 6,565,517 | 11,529,629 | |||||||||||||||
| Intersegment eliminations | (336) | (448) | (916) | (631) | (2,331) | |||||||||||||||
| Revenue | $ | 52,516,556 | $ | 49,154,171 | $ | 53,405,695 | $ | 58,912,421 | $ | 213,988,843 |
The following illustrates revised reportable segment operating income for the periods indicated
| Fiscal Year Ended September 30, 2021 | ||||||||||||||||||||
| Segment Operating Income | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Fiscal Year | |||||||||||||||
| (As Revised) | (As Revised) | (As Revised) | (As Revised) | (As Revised) | ||||||||||||||||
| U.S. Healthcare Solutions | $ | 565,927 | $ | 654,715 | $ | 529,790 | $ | 507,486 | $ | 2,257,918 | ||||||||||
| International Healthcare Solutions | 50,989 | 51,843 | 100,831 | 186,623 | 390,286 | |||||||||||||||
| Total segment operating income | $ | 616,916 | $ | 706,558 | $ | 630,621 | $ | 694,109 | $ | 2,648,204 |
The following reconciles total segment operating income to income before income taxes for the periods indicated
| Fiscal Year Ended September 30, 2021 | ||||||||||||||||||||
| (in thousands) | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Fiscal Year | |||||||||||||||
| Total segment operating income | $ | 616,916 | $ | 706,558 | $ | 630,621 | $ | 694,109 | $ | 2,648,204 | ||||||||||
| Gains from antitrust litigation settlements | - | - | 147,432 | 21,362 | 168,794 | |||||||||||||||
| LIFO credit | 25,727 | 20,918 | 113,920 | 42,463 | 203,028 | |||||||||||||||
| Acquisition-related intangibles amortization | (25,034) | (24,973) | (44,282) | (81,932) | (176,221) | |||||||||||||||
| Employee severance, litigation, and other | (70,381) | (78,156) | (226,964) | (96,410) | (471,911) | |||||||||||||||
| Goodwill impairment | - | - | - | (6,373) | (6,373) | |||||||||||||||
| Impairment of assets | - | - | - | (11,324) | (11,324) | |||||||||||||||
| Operating income | 547,228 | 624,347 | 620,727 | 561,895 | 2,354,197 | |||||||||||||||
| Other (income) loss | (14,268) | 23,310 | (4,141) | (46,637) | (41,736) | |||||||||||||||
| Interest expense, net | 33,614 | 34,526 | 51,338 | 54,596 | 174,074 | |||||||||||||||
| Income before income taxes | $ | 527,882 | $ | 566,511 | $ | 573,530 | $ | 553,936 | $ | 2,221,859 |